Biovie Inc (BIVI)

Official site

HEALTHCARE • BIOTECHNOLOGY • NASDAQ

$1.44

-0.04 (-2.59%)

Market Cap: $10.25M

Last updated: Oct 16, 2026 at 1:54 PM ET

Earnings

Performance (10Y)

Beat Rate

57%(13/23)

Avg Surprise

-46.54%

Period	Reported	Est.	Range	Surprise	B/M	Analysts	Revisions	YoY
Jun 30, 2026Jun 26 Reported Aug 12, 2026Reported Aug 12	$-0.70	$-0.52	$-0.52 - $-0.52	-34.62%	Miss	1	0 1 30d	+93.7%
Mar 31, 2026Mar 26 Reported May 11, 2026Reported May 11	$-0.70	$-0.77	$-0.77 - $-0.77	+9.27%	Beat	1	0 1 30d	+53.4%
Dec 31, 2025Dec 25 Reported Feb 6, 2026Reported Feb 6	$-0.77	$-0.92	$-0.92 - $-0.92	+16.71%	Beat	1	0 1 30d	+83.3%
Sep 30, 2025Sep 25 Reported Nov 10, 2025Reported Nov 10	$-0.98	$-0.79	$-0.79 - $-0.79	-24.05%	Miss	1	0 1 30d	-40.1%
Jun 30, 2025Jun 25 Reported Aug 15, 2025Reported Aug 15	$-11.05	$-3.60	$-3.60 - $-3.60	-206.94%	Miss	1	No revisions (30d)	-1284.4%
Mar 31, 2025Mar 25 Reported May 12, 2025Reported May 12	$-1.50	N/A	-	+53.13%	Beat	1	No revisions (30d)	+92.5%
Dec 31, 2024Dec 24 Reported Feb 11, 2025Reported Feb 11	$-4.60	N/A	-	+71.25%	Beat	0	No revisions (30d)	+79.1%
Sep 30, 2024Sep 24 Reported Nov 13, 2024Reported Nov 13	$-0.70	$-0.27	$-0.27 - $-0.27	-159.15%	Miss	0	No revisions (30d)	+97.6%
Jun 30, 2024Jun 24 Reported Sep 30, 2024Reported Sep 30	$-0.80	$-0.15	$-0.15 - $-0.15	-432.13%	Miss	0	No revisions (30d)	+96.5%
Mar 31, 2024Mar 24 Reported May 14, 2024Reported May 14	$-20.00	$-25.00	$-25.00 - $-25.00	+20.00%	Beat	0	No revisions (30d)	+53.5%
Dec 31, 2023Dec 23 Reported Feb 12, 2024Reported Feb 12	$-22.00	$-27.50	$-27.50 - $-27.50	+20.00%	Beat	1	No revisions (30d)	+56.0%
Sep 30, 2023Sep 23 Reported Nov 8, 2023Reported Nov 8	$-29.00	$-31.00	$-31.00 - $-31.00	+6.45%	Beat	1	No revisions (30d)	+23.7%
Jun 30, 2023Jun 23 Reported Aug 16, 2023Reported Aug 16	$-23.00	$-40.00	$-40.03 - $-39.97	+42.50%	Beat	2	No revisions (30d)	-6869.7%
Mar 31, 2023Mar 23 Reported May 12, 2023Reported May 12	$-43.00	$-35.50	$-35.55 - $-35.46	-21.13%	Miss	2	No revisions (30d)	-53.6%
Dec 31, 2022Dec 22 Reported Feb 10, 2023Reported Feb 10	$-50.00	$-25.25	$-25.33 - $-25.17	-98.02%	Miss	4	No revisions (30d)	-127.3%
Sep 30, 2022Sep 22 Reported Nov 4, 2022Reported Nov 4	$-38.00	$-28.50	$-28.55 - $-28.46	-33.33%	Miss	2	No revisions (30d)	-16421.7%
Jun 30, 2022Jun 22 Reported Sep 27, 2022Reported Sep 27	$-0.33	$-0.37	$-0.55 - $-0.25	+10.81%	Beat	4	No revisions (30d)	+100.0%
Mar 31, 2022Mar 22 Reported May 11, 2022Reported May 11	$-28.00	N/A	-	+60.56%	Beat	3	No revisions (30d)	-27.3%
Dec 31, 2021Dec 21 Reported Feb 8, 2022Reported Feb 8	$-22.00	$-41.00	$-41.10 - $-40.90	+46.34%	Beat	2	0 1 30d	+0.0%
Sep 30, 2021Sep 21 Reported Nov 10, 2021Reported Nov 10	$-0.23	$-0.23	$-0.23 - $-0.23	+0.00%	Beat	0	No revisions (30d)	+93.0%
Jun 30, 2021Jun 21 Reported Aug 30, 2021Reported Aug 30	$-1018.77	$-232.00	$-232.00 - $-232.00	-339.13%	Miss	1	No revisions (30d)	-27584.0%
Mar 31, 2021Mar 21 Reported May 10, 2021Reported May 10	$-22.00	$-23.00	-	+4.35%	Beat	-	-	-31328.6%
Dec 31, 2020Dec 20 Reported Jan 29, 2021Reported Jan 29	$-22.00	$-12.00	-	-83.33%	Miss	-	-	-1805.4%
Sep 30, 2020Sep 20 Reported Nov 5, 2020Reported Nov 5	$-3.28	N/A	-	N/A	Beat	-	-	+35.2%
Jun 30, 2020Jun 20 Reported Aug 6, 2020Reported Aug 6	$-3.68	N/A	-	N/A	Beat	-	-	-1372.0%
Mar 31, 2020Mar 20 Reported May 13, 2020Reported May 13	$-0.07	N/A	-	N/A	Beat	-	-	+72.0%
Dec 31, 2019Dec 19 Reported Feb 13, 2020Reported Feb 13	$1.29	N/A	-	N/A	Beat	-	-	+479.4%
Sep 30, 2019Sep 19 Reported Nov 19, 2019Reported Nov 19	$-5.06	N/A	-	N/A	Beat	-	-	-2430.0%
Jun 30, 2019Jun 19 Reported Sep 26, 2019Reported Sep 26	$-0.25	N/A	-	N/A	Beat	-	-	-26.6%
Mar 31, 2019Mar 19 Reported May 10, 2019Reported May 10	$-0.25	N/A	-	N/A	Beat	-	-	+66.0%
Dec 31, 2018Dec 18 Reported Feb 12, 2019Reported Feb 12	$-0.34	N/A	-	N/A	Beat	-	-	+61.9%
Sep 30, 2018Sep 18 Reported Oct 5, 2018Reported Oct 5	$-0.20	N/A	-	N/A	Beat	-	-	+69.8%
Jun 30, 2018Jun 18 Reported Sep 30, 2018Reported Sep 30	$-0.20	N/A	-	N/A	Beat	-	-	+77.8%
Mar 31, 2018Mar 18 Reported May 14, 2018Reported May 14	$-0.73	N/A	-	N/A	Beat	-	-	-21.8%
Dec 31, 2017Dec 17 Reported Feb 14, 2018Reported Feb 14	$-0.89	N/A	-	N/A	Beat	-	-	-266.1%
Sep 30, 2017Sep 17 Reported Nov 8, 2017Reported Nov 8	$-0.66	N/A	-	N/A	Beat	-	-	-
Jun 30, 2017Jun 17 Reported Aug 23, 2017Reported Aug 23	$-0.89	N/A	-	N/A	Beat	-	-	-
Mar 31, 2017Mar 17 Reported May 8, 2017Reported May 8	$-0.60	N/A	-	N/A	Beat	-	-	-
Dec 31, 2016Dec 16 Reported Feb 7, 2017Reported Feb 7	$-0.24	N/A	-	N/A	Beat	-	-	-

Key Metrics

Valuation
P/E Ratio	-0.46	EV/EBITDA	N/A
Price/FCF	N/A	FCF Yield	N/A
Profitability
Profit Margin	0.00%	Operating Margin	0.00%
ROE	-150.80%	ROIC	N/A
Financial Health
Debt/Equity	0.00x	Interest Coverage	-1265.39x
Current Ratio	3.59x	Quick Ratio	3.59x
Trading Statistics
Beta	0.73	Avg Volume	343.02K
52-Week High	$3.79	52-Week Low	$0.82

Technical Indicators Dashboard

Moving Averages

SMA 10$1.32

SMA 20$1.45

SMA 50$1.64

SMA 200$1.51

EMA 10$1.31

EMA 20$1.43

EMA 50$1.58

EMA 200$1.95

MACD

Line: -0.15Signal: -0.12Hist: -0.03

ADX

ADX: 17.3+DI: 18.2-DI: 29.6

Aroon & PSAR

Aroon Up8.0

Aroon Down100.0

PSAR$2.19

Bollinger Bands

Upper Band$1.77

Lower Band$1.13

%B Position4452%(Upper)

Band Width0.00

RSI (14-Day)

Oversold

28.8

Momentum Oscillators

Stoch %K0.6

Stoch %D6.6

Williams %R-100.0

ROC (10d)-23.1%

Momentum-0.34

CCI (20d)-162.8

MFI (14d)15.1

Volatility Measures

ATR (14d)$0.14(12.4%)

StdDev (20d)0.16

Hist Vol64.4%(High)

Volume Flow

VWAP$1.15

OBV215.2M

AD Line3.7B

CMF (20d)-0.643

Volume Metrics

Avg Vol (20d)231.6K

Vol Ratio0.7x

VWMA (20d)$1.47

Pivot Points

R3$1.32

R2$1.29

R1$1.22

Pivot Point$1.19

S1$1.12

S2$1.09

S3$1.02

Advanced Oscillators

TSI-30.22

Ultimate Osc21.7

KST-225.71

Financial Data

Quarter	Jun 2026	Mar 2026	Dec 2025	Sep 2025	Jun 2025	Mar 2025	Dec 2024	Sep 2024	Jun 2024	Mar 2024	Dec 2023	Sep 2023
Total Revenue	N/A	$0	$0	$0	$0	$0	$0	$0	$0	$0	$0	$0
Cost of Revenue	N/A	$0	$0	$0	$57,344	$0	$0	$0	$57,344	$0	$0	$0
Gross Profit	N/A	$0	$0	$0	$-57,344	$0	$0	$0	$-57,344	$0	$0	$0

Operating Expenses	$5.72M	$5.39M	$6.26M	$5.28M	$3.61M	$2.99M	$7.29M	$4.12M	$4.73M	$7.73M	$8.78M	$10.88M
R&D	$3.58M	$3.18M	$4.27M	$2.94M	$1.22M	$1.34M	$4.70M	$1.99M	$2.05M	$5.70M	$6.47M	$8.88M
SG&A	$2.13M	$2.15M	$1.94M	$2.29M	$2.38M	$1.59M	$2.53M	$2.07M	$2.68M	$1.97M	$2.25M	$1.94M
Operating Income	$-5,719,456	$-5,385,377	$-6,262,305	$-5,284,595	$-3,663,085	$-2,988,204	$-7,292,829	$-4,122,082	$-4,790,300	$-7,732,055	$-8,781,408	$-10,875,821

Interest Income	$77,902	$121,045	$198,797	$199,027	$178,942	$197,494	$253,036	$223,557	$272,517	$183,933	$218,029	$462,223
Interest Expense	$3,978	$5,967	$5,967	$1,989	$4,998	$4,998	$66,700	$256,024	$439,943	$628,711	$820,600	$1.00M
Income Before Tax	$-5,645,532	$-5,270,299	$-6,069,475	$-5,087,557	$-3,489,141	$-2,788,418	$-7,112,529	$-4,152,032	$-4,940,794	$-8,067,830	$-8,401,445	$-10,710,464
Income Tax Expense	$0	$0	$0	$0	$7.16M	$0	$0	$-4,477,073	$439,943	$0	$820,600	$0

Net Income	$-5,645,532	$-5,270,299	$-6,069,475	$-5,087,557	$-3,489,141	$-2,788,418	$-7,112,529	$-4,152,032	$-4,940,794	$-8,067,830	$-8,401,445	$-10,710,464

EBITDA	$-5,713,148	$-5,328,032	$-6,204,961	$-5,227,251	$-3,426,799	$-2,923,569	$-7,241,521	$-4,052,765	$-4,443,507	$-7,565,708	$-7,682,426	$-10,072,850
EBIT	$-5,719,456	$-5,385,377	$-6,262,305	$-5,284,595	$-3,484,143	$-2,980,914	$-7,298,865	$-4,119,565	$-4,500,851	$-7,623,052	$-7,798,874	$-10,168,019

* Some calculated fields are derived from available data when not provided by source

Related GNG Research

No research available

Be the first to write about BIVI

News

BIVI 6-DAY DEADLINE ALERT: Hagens Berman, National Trial Attorneys, Encourages BioVie (BIVI) Investors with Substantial Losses to Contact its Attorneys Before Mar. 19th Deadline in Securities Fraud Class Action Over Failed Phase 3 Clinical Trial

Hagens Berman is encouraging BioVie Inc. (BIVI) investors who suffered substantial losses to contact their attorneys before the March 19...

TMX Newsfile•Sep 21, 2026 1:22 AM ET9/21/26•Bearish

Form 8K Biovie Inc For: 14 September By Investing.com

This article from Investing.com reports on a Form 8K filing by Biovie Inc. for September 14. The content primarily consists of the title and a repetition of the company and date...

Investing.com Nigeria•Sep 14, 2026 7:22 AM ET9/14/26•Neutral

BioVie Inc. CEO Cuong V Do buys $31,636 in company stock

BioVie Inc. CEO Cuong V Do recently purchased 15,210 shares of company stock for $31,636 at a weighted average price of $2.08 per share. This transaction increases his direct beneficial ownership to 16,117 shares....

Investing.com Canada•Aug 28, 2026 1:16 PM ET8/28/26•Bullish

Biovie CFO Joanne Kim buys $5,450 in Biovie Inc. stock By Investing.com

Biovie's CFO, Joanne Kim, recently purchased 2,500 shares of the company's common stock for $5,450, at a price of $2.18 per share. This insider transaction follows a period of strong performance for Biovie shares...

Investing.com Canada•Aug 28, 2026 1:16 PM ET8/28/26•Bullish

12 Health Care Stocks Moving In Thursday's Pre-Market Session

This article lists 12 healthcare stocks that experienced significant movement in Thursday's pre-market session. It categorizes them into gainers and losers, providing their stock performance, current share price...

Sahm•Aug 21, 2026 10:42 AM ET8/21/26•Somewhat-Bullish

BIVI Valuation and Fair Value

P/E: -0.5x
P/B: 1.0x

See GNG's fair value

BIVI Profitability: Margins, ROIC and FCF

Operating margin: 0.0%
Net margin: 0.0%
ROE: -150.8%

BIVI Competitors

Company	Ticker
CytoMed Therapeutics Limited Ordinary Shares	GDTC
Lantern Pharma Inc	LTRN
NLS Pharmaceutics AG	NLSP
Bullfrog AI Holdings, Inc. Common Stock	BFRG
Cytosorbents Crp	CTSO
Karyopharm Therapeutics Inc	KPTI
Phio Pharmaceuticals Corp	PHIO
Neuroone Medical Technologies Corp	NMTC

Sector: Healthcare

BIVI Earnings: Beat Rate and Next Report

Beat rate: 4 of 8 quarters (50.0%)
Average surprise: -50.1%

Frequently Asked Questions About BIVI

Does BIVI pay dividends?

Biovie Inc (BIVI) does not currently pay a regular dividend.

What is BIVI's market cap?

Biovie Inc (BIVI) has a market capitalization of $10.25M with a current stock price of $1.44.

Get full access to GNG Research

Create a free account to access portfolio tracking, advanced tools, and more.

Create Free Account Log In